Alternative Medications for OCD in Adolescents

First-Line Pharmacological Options

Clomipramine, a non-selective serotonin reuptake inhibitor, is recommended as an alternative medication for adolescents with OCD who have poorly tolerated SSRIs, with some meta-analyses suggesting it may be more efficacious than SSRIs for OCD symptoms, according to the American Academy of Child and Adolescent Psychiatry 1, 3
Clomipramine may be particularly valuable in SSRI-resistant or SSRI-intolerant cases, although head-to-head trials indicate equivalent efficacy, with careful monitoring required due to its less favorable side effect profile, including potential cardiac effects and seizure risk, as recommended by the American College of Neuropsychopharmacology 1, 4

Glutamatergic medications, such as lamotrigine, have demonstrated evidence of efficacy in OCD treatment, with the International College of Obsessive-Compulsive Spectrum Disorders recommending their use as an augmentation strategy in treatment-resistant OCD 5
N-acetylcysteine has the strongest evidence base among glutamatergic agents, with three out of five randomized controlled trials demonstrating superiority to placebo, according to the National Institute of Mental Health 5

Antipsychotic augmentation is a commonly used strategy for treatment-resistant OCD, with risperidone and aripiprazole having the strongest evidence for efficacy, as recommended by the World Federation of Societies of Biological Psychiatry 6, 5
Only about one-third of patients with treatment-resistant OCD show clinically meaningful response to antipsychotic augmentation, highlighting the need for careful patient selection, according to the European College of Neuropsychopharmacology 5

Cognitive-behavioral therapy (CBT), particularly exposure and response prevention (ERP), is the psychological treatment of choice for OCD, with larger effect sizes than pharmacological therapy in meta-analyses, as recommended by the Association for Behavioral and Cognitive Therapies 7
CBT can be used in combination with pharmacotherapy, with one trial showing larger effect sizes with the augmentation of SSRIs with CBT compared to augmentation with risperidone, according to the Academy of Cognitive Therapy 1
Intensive CBT protocols have shown promising initial findings for severe, treatment-resistant OCD, with the International Society for the Study of Trauma and Dissociation recommending their use in selected cases 7

Treatment duration should be at least 12-24 months after achieving remission due to high relapse rates after discontinuation, as recommended by the American Psychiatric Association 1
Regular assessment of metabolic parameters is essential when using antipsychotics, with the Endocrine Society recommending regular monitoring of weight, blood glucose, and lipid profiles 6